Esq CPA - Ocean Biomedical Chief Officer
| OCEA Stock | 0.72 0.01 1.41% |
Executive
Esq CPA is Chief Officer of Ocean Biomedical
| Age | 59 |
| Address | Room 325, 55 Claverick Street, Providence, RI, United States, 02903 |
| Phone | 401 444 7375 |
| Web | https://www.oceanbiomedical.com |
Ocean Biomedical Management Efficiency
The company has return on total asset (ROA) of (6.8199) % which means that it has lost $6.8199 on every $100 spent on assets. This is way below average. Ocean Biomedical's management efficiency ratios could be used to measure how well Ocean Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ocean Biomedical's Return On Tangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0, whereas Return On Capital Employed is projected to grow to (0.03). At present, Ocean Biomedical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 133.4 M, whereas Net Tangible Assets are projected to grow to (5.7 M).Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Yang | Elevation Oncology | N/A | |
| Verender Badial | Zura Bio Limited | 52 | |
| John SullivanBolyai | Hepion Pharmaceuticals | 76 | |
| David Brady | Zura Bio Limited | N/A | |
| John Cavan | Hepion Pharmaceuticals | 66 | |
| Kiran MBBS | Zura Bio Limited | 51 | |
| Patrick Mayo | Hepion Pharmaceuticals | N/A | |
| Michael Howell | Zura Bio Limited | 47 | |
| Biren Shah | Elevation Oncology | N/A | |
| Candice Masse | Elevation Oncology | N/A | |
| Kevin CPA | Enveric Biosciences | 60 | |
| Kimberly Davis | Zura Bio Limited | 56 | |
| Theresa Lowry | Zura Bio Limited | 50 | |
| Daniel Trepanier | Hepion Pharmaceuticals | N/A | |
| Gary Whale | Zura Bio Limited | 50 | |
Management Performance
| Return On Asset | -6.82 |
Ocean Biomedical Leadership Team
Elected by the shareholders, the Ocean Biomedical's board of directors comprises two types of representatives: Ocean Biomedical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ocean. The board's role is to monitor Ocean Biomedical's management team and ensure that shareholders' interests are well served. Ocean Biomedical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ocean Biomedical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MD MBA, Chief Officer | ||
| Gurinder MBA, CFO Treasurer | ||
| Esq CPA, Chief Officer | ||
| Robert Sweeney, Chief Secretary | ||
| Elizabeth MBA, CEO Director | ||
| Jack MD, Chairman Founder | ||
| Jonathan MD, Chairman Founder | ||
| MPH MD, Interim Director |
Ocean Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ocean Biomedical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -6.82 | ||||
| Current Valuation | 36.97 M | ||||
| Shares Outstanding | 34.65 M | ||||
| Shares Owned By Insiders | 71.98 % | ||||
| Shares Owned By Institutions | 11.62 % | ||||
| Number Of Shares Shorted | 165.46 K | ||||
| Price To Book | 100.67 X | ||||
| EBITDA | (957.74 K) | ||||
| Net Income | (958.43 K) | ||||
| Total Debt | 2.15 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocean Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.